The adoptive transfer of behavioral phenotype via the intestinal microbiota: Experimental evidence and clinical implications

Current Opinion in Microbiology

Volumn 16, Issue 3, 2013, Pages 240-245

  Collins, Stephen M ^a   Kassam, Zain ^a   Bercik, Premysl ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADOPTIVE TRANSFER; CENTRAL NERVOUS SYSTEM; CLOSTRIDIUM DIFFICILE INFECTION; DIABETES MELLITUS; DONOR; ENTERITIS; FECAL MICROBIOTA TRANSPLANTATION; FECES MICROFLORA; HUMAN; INTESTINE FLORA; MICROBIOME; NONHUMAN; RECIPIENT; REVIEW; SCREENING; SIGNAL TRANSDUCTION; TRANSPLANTATION;

CLOSTRIDIUM DIFFICILE; MUS;

EID: 84881557235     PISSN: 13695274     EISSN: 18790364     Source Type: Journal    
DOI: 10.1016/j.mib.2013.06.004     Document Type: Review

References (55)

1. Eckburg P.B., Bik E.M., Bernstein C.N., Purdom E., Dethlefsen L., Sargent M., Gill S.R., Nelson K.E., Relman D.A. Diversity of the human intestinal microbial flora. Science 2005, 308:1635-1638.
2. Turnbaugh P.J., Hamady M., Yatsunenko T., Cantarel B.L., Duncan A., Ley R.E., Sogin M.L., Jones W.J., Roe B.A., Affourtit J.P., et al. A core gut microbiome in obese and lean twins. Nature 2009, 457:480-484.
3. Lozupone C.A., Stombaugh J.I., Gordon J.I., Jansson J.K., Knight R. Diversity, stability and resilience of the human gut microbiota. Nature 2012, 489:220-230.
4. de Vos W.M., de Vos E.A. Role of the intestinal microbiome in health and disease: from correlation to causation. Nutr Rev 2012, 70(Suppl 1):S45-S56.
5. Riordan S.M., Williams R. Treatment of hepatic encephalopathy. N Engl J Med 1997, 337:473-479.
6. Collins S.M., Surette M., Bercik P. The interplay between the intestinal microbiota and the brain. Nat Rev Microbiol 2012, 10:735-742.
7. Cryan J.F., Holmes A. The ascent of mouse: advances in modeling human depression and anxiety. Nat Rev Drug Discov 2005, 4:775-790.
8. York J.M., Blevins N.A., Baynard T., Freund G.G. Mouse testing methods in psychoneuroimmunology: an overview of how to measure sickness, depressive/anxietal, cognitive, and physical activity behaviors. Methods Mol Biol 2012, 934:243-276.
9. Crawley J.N. Exploratory behavior models of anxiety in mice. Neurosci Biobehav Rev 1985, 9:37-44.
10. Sudo N., Chida Y., Alba Y., Sonoda J., Oyama N., Yu X.N., Kubo C., Koga Y. Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice. J Physiol 2004, 558:263-275.
11. Neufeld K.M., Kang N., Bienenstock J., Foster J.A. Reduced anxiety-like behavior and central neurochemical change in germ-free mice. Neurogastroenterol Motil 2011, 23:255-264.
12. Diaz Heijtz R., Wang S., Anuar F., Qian Y., Bjorkholm B., Samuelsson A., Hibberd M.L., Forssberg H., Petterson S. Normal gut microbiota modulates brain development and behavior. Proc Natl Acad Sci U S A 2011, 108:3047-3052.
13. Li W., Dowd S.E., Scurlock B., Acosta-Martinez V., Lyte M. Memory and learning behavior in mice is temporally associated with diet-induced alterations in gut bacteria. Physiol Behav 2009, 96:557-567.
14. Bercik P., Denou E., Collins J., Jackson W., Lu J., Jury J., Deng Y., Biennerhassett P., Macri J., McCoy K.D., et al. The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology 2011, 141:599-609.
15. Desbonnet L., Garrett L., Clarke G., Kiely B., Cryan J.F., Dinan T.G. Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression. Neuroscience 2010, 170:1179-1188.
16. Bercik P., Verdu E.F., Foster J.A., Macri J., Potter M., Huang X., Malinowski P., Jackson W., Biennerhassett P., Neufeld K.A., et al. Chronic gastrointestinal inflammation induces anxiety-like behavior and alters central nervous system biochemistry in mice. Gastroenterology 2010, 139:2102-2112.
17. Matsumoto M., Kibe R., Ooga T., Aiba Y., Sawaki E., Koga Y., Benno Y. Cerebral low-molecular metabolites influenced by intestinal microbiota: a pilot study. Front Syst Neurosci 2013, 7:9.
18. Bravo J.A., Forsythe P., Chew M.V., Escaravage E., Savignac H.M., Dinan T.G., Bienenstock J., Cryan J.F. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci U S A 2011, 108:10650-16055.
19. Desbonnet L., Garrett L., Clarke G., Bienenstock J., Dinan T.G. The probiotic Bifidobacteria infantis: an assessment of potential antidepressant properties in the rat. J Psychiatr Res 2008, 43:164-174.
20. Wikoff W.R., Anfora A.T., Liu J., Schultz P.G., Lesley S.A., Peters E.C., Siuzdak G. Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc Natl Acad Sci U S A 2009, 106:3698-3703.
21. Hanstock T.L., Mallet P.E., Clayton E.H. Increased plasma d-lactic acid associated with impaired memory in rats. Physiol Behav 2010, 101:653-659.
22. Turnbaugh P.J., Ley R.E., Mahowald M.A., Magrini V., Mardis E.R., Gordon J.I. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006, 444:1027-1031.
23. Vrieze A., Van Nood E., Holleman F., Salojärvi J., Kootte R.S., Bartelsman J.F., Dallinga-Thie G.M., Ackermans M.T., Serlie M.J., Oozeer R., et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 2012, 143:913-916.
24. Le Roy T., Llopis M., Lepage P., Bruneau A., Rabot S., Bevilacqua C., Martin P., Philippe C., Walker F., Bado A., et al. Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice. Gut 2012, Nov 29 [Epub ahead of print] PubMed PMID: 23197411.
25. van Nood E., Vrieze A., Nieuwdorp M., Fuentes S., Zoetendal E.G., de Vos W.M., Visser C.E., Kuijper E.J., Bartelsman J.F., Tijssen J.G., et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 2013, 368:407-415.
26. Borody T.J., Khoruts A. Fecal microbiota transplantation and emerging applications. Nat Rev Gastroenterol Hepatol 2011, 9:88-96.
27. Bouwknecht J.A., Paylor R. Behavioral and physiological mouse assays for anxiety: a survey in nine mouse strains. Behav Brain Res 2002, 136:489-501.
28. Kovacs A., Ben-Jacob N., Tayem H., Halperin E., Iraqi F.A., Gophna U. Genotype is a stronger determinant than sex of the mouse gut microbiota. Microb Ecol 2011, 61:423-428.
29. Deltheil T., Guiard B.P., Cerdan J., David D.J., Tanaka K.F., Repérant C., Guilloux J.P., Coudoré F., Hen R., Gardier A.M. Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice. Neuropharmacology 2008, 55:1006-1014.
30. Cryan J.F., Dinan T.G. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci 2012, 13:701-712.
31. Tillisch K., Labus J., Kilpatrick L., Jiang Z., Stains J., Ebrat B., Guyonnet D., Legrain-Raspaud S., Trotin B., Naliboff B., Mayer E.A. Consumption of fermented milk product with probiotic modulates brain activity. Gastroenterology 2013, 144:1394-1401.
32. Eiseman B., Silen W., Bascom G.S., Kauvar A.J. Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery 1958, 44:854-859.
33. Bakken J.S. Fecal bacteriotherapy for recurrent Clostridium difficile infection. Anaerobe 2009, 15:285-289.
34. Landy J., Al-Hassi H.O., McLaughlin S.D., Walker A.W., Ciclitira P.J., Nicholls R.J., Clark S.K., Hart A.L. Review article: faecal transplantation therapy for gastrointestinal disease. Aliment Pharmacol Ther 2011, 34:409-415.
35. Kassam Z., Hundal R., Marshall J.K., Lee C.H. Fecal transplant via retention enema for refractory or recurrent Clostridium difficile infection. Arch Intern Med 2012, 172:191-193.
36. Gough E., Shaikh H., Manges A.R. Systematic review of intestinal microbiota transplantation for recurrent Clostridium difficile infection. Clin Infect Dis 2011, 53:994-1002.
37. Guo B., Harstall C., Louie T., Veldhuzen van Zanten S., Dieleman L.A. Systematic review: faecal transplantation for the treatment of Clostridium difficile-associated disease. Aliment Pharmacol Ther 2012, 35:865-875.
38. Kassam Z., Lee C.H., Yuan Y., Hunt R.H. Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis. Am J Gastroenterol 2013, 108:500-508.
39. Zipursky J.S., Sidorsky T.I., Freedman C.A., Sidorsky M.N., Kirkland K.B. Patient attitudes towards the use of fecal microbiota transplantation in the treatment of recurrent Clostridium difficile infection. Clin Infect Dis 2012, 55:1652-1658.
40. Jiang Z.D., Hoang L.N., Lasco T.M., Garey K.W., Dupont H.L. Physicians attitudes towards the use of fecal transplantation for recurrent Clostridium difficile infection in a metropolitan area. Clin Infect Dis 2013, [Epub ahead of print].
41. Anderson J.L., Edney R.J., Whelan K. Systematic review: faecal microbiota transplantation in the management of inflammatory bowel disease. Aliment Pharmacol Ther 2012, 36:503-516.
42. Aroniadis O.C., Brandt L.J. Fecal microbiota transplantation: past, present, future. Curr Opin Gastroenterol 2013, 29:79-84.
43. Brandt L.J. American Journal of Gastroenterology Lecture: intestinal microbiota and the role of fecal microbiota transplant (FMT) in treatment of C. difficile infection. Am J Gastroenterol 2013, 108:177-185.
44. Allen-Vercoe E., Reid G., Viner N., Gloor G.B., Hota S., Kim P., Lee C., O'Doherty K.C., Vanner S.J., Weese J.S., et al. Canadian Working Group report on fecal microbiota therapy: microbial ecosystem therapeutics. Can J Gastroenterol 2012, 26:457-462.
45. Bakken J.S., Borody T., Brandt L.J., Brill J.V., Demarco D.C., Franzo M.A., Kelly C., Khoruts A., Louie T., Martinelli L.P., et al. Treating Clostridium difficile infection with fecal microbiota transplantation. Clin Gastroenterol Hepatol 2011, 9:1044-1049.
46. Borody T.J., Campbell Fecal microbiota transplantation: techniques, applications, and issues. Gasterol Clin North Am 2012, 41:781-803.
47. Brandt L.J., Aroniadis O.C., Mellow M., Kanatzar A., Kelly C., Park T., Stollman N., Rohlke F., Surawicz C. Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection. Am J Gastroenterol 2012, 107:1079-1087.
48. Borody T.J., Leis S., Campbell J., Torres M., Nowak A. Fecal microbiota transplantation (FMT) in multiple sclerosis (MS). Am J Gastroenterol 2011, 106:S352.
49. Berer K., Mues M., Koutrolos M., Rasbi Z.A., Boziki M., Johner C., Wekerle H., Krishnamoorthy G. Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature 2011, 479:538-541.
50. Anathaswamy A. Faecal transplant eases symptoms of Parkinson's. New Scientist 2011, 2796:8-9.
51. Borody T.J., Nowak A., Torres M., Campbell J., Finlayson S., Leis S.M. Bacteriotherapy in Chronic Fatigue Syndrome (CFS): a retrospective review. Am J Gastroenterol 2012, 107:S591-S592.
52. Borody T.J., Torres M., Campbell J., Hills L., Ketheeswaran Treatment of severe constipation improves Parkinson's disease (PD) symptoms. Am J Gastroenterol 2009, 104:S999.
53. Finegold S. State of the art; microbiology in health and disease. Intestinal bacterial flora in autism. Anaerobe 2011, 17:367-368.
54. Song Y., Liu C., Finegold S.M. Real-time PCR quantitation of clostridia in feces of autistic children. Appl Environ Microbiol 2004, 70:6459-6465.
55. Sandler R.H., Finegold S.M., Bolte E.R., Buchanan C.P., Maxwell A.P., Vaisanen M.L., Nelson M.N., Wexler H.M. Short-term benefit from oral vancomyin treatment of regressive-onset autism. J Child Neurol 2000, 15:429-435.